Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jan 11;10(8):725-727.
doi: 10.1093/ehjcvp/pvae077.

Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis

Shinya Goto  1 , Shinichi Goto  2
Affiliations
Editorial

Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis

Shinya Goto et al. Eur Heart J Cardiovasc Pharmacother. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential importance of LDL -C lowering for prevention of venous thromboembolism.
See this image and copyright information in PMC

Comment on

  • Role of PCSK9 inhibitors in venous thromboembolism: current evidence and unmet clinical needs.
    Zuin M, Corsini A, Dalla Valle C, De Rosa C, Maloberti A, Mojoli M, Rizzo M, Ciccirillo F, Madrid A, Riccio C, Grimaldi M, Colivicchi F, Oliva F, Temporelli PL; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) Working Group on Cardiological Chronicity. Zuin M, et al. Eur Heart J Cardiovasc Pharmacother. 2025 Jan 11;10(8):719-724. doi: 10.1093/ehjcvp/pvae076. Eur Heart J Cardiovasc Pharmacother. 2025. PMID: 39406397 Free PMC article. Review.

Similar articles

See all similar articles

References

    1. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 2017;376:1713–1722. - PubMed
    1. Libby P, Schoenbeck U, Mach F, Selwyn AP, Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med 1998;104:14S–18S. - PubMed
    1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:310–318. - PubMed
    1. van der Stoep M, Korporaal SJ, Van Eck M. High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res 2014;103:362–371. - PubMed
    1. Zuin MCA, Valle CD, Rosa CD, Maloberti A, Mojoli M, Rizzo M, Ciccirillo F, Madrid A, Riccio C, Grimaldi M, Colivicchi F, Oliva F, Temporelli PL. Role of PCSK9 inhibitor in venous thromoembolism: current evidece and unmet needs. Eur Heart J-Cardiovasc Pharmacother 2024;in press. 10.1093/ehjcvp/pvae076 - DOI - PMC - PubMed